SYNERGENZ

Welcome to the Brand page for “SYNERGENZ”, which is offered here for Medical, diagnostic and prognostic screening kits and testing kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing;medical, diagnostic and prognostic screening and testing services for cancer, cardio-pulmonary diseases, emphysema, chronic obstructive pulmonary disease (copd), occupational chronic obstructive pulmonary disease (ocopd), asthma, impaired lung function, heart attack and stroke; information, advisory and consulting services in the field of medical, diagnostic and prognostic screening and testing services for cancer, cardiopulmonary diseases, emphysema, chronic obstructive pulmonary disease (copd), occupational chronic obstructive pulmonary disease (ocopd), asthma, impaired lung function, heart attack and stroke;.

Its status is currently believed to be active. Its class is unavailable. “SYNERGENZ” is believed to be currently owned by “SYNERGENZ BIOSCIENCE LIMITED”.


Owner:
SYNERGENZ BIOSCIENCE LIMITED
Owner Details
Description:
Medical, diagnostic and prognostic screening kits and testing kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing;Medical, diagnostic and prognostic screening and testing services for cancer, cardio-pulmonary diseases, emphysema, chronic obstructive pulmonary disease (COPD), occupational chronic obstructive pulmonary disease (OCOPD), asthma, impaired lung function, heart attack and stroke; information, advisory and consulting services in the field of medical, diagnostic and prognostic screening and testing services for cancer, cardiopulmonary diseases, emphysema, chronic obstructive pulmonary disease (COPD), occupational chronic obstructive pulmonary disease (OCOPD), asthma, impaired lung function, heart attack and stroke;
Categories: MEDICAL